EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-COV-2 mutations in North Rift, Kenya

Elius Mbogori iD, Kelvin Thiongo, Harrison Yunying Deng, Caroline Wangui Gikunyu iD, Winfrida Cheriro, Stanslaus Musyoki, Richard Biegon, Damaris Matoke-Muhia, Kirtika Patel, Binhua Liang, Elijah Songok

PLOS One · 2025

DOI: 10.1371/journal.pone.0325133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Elius Mbogori und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Department, Moi Teaching and Referral Hospital, Eldoret, Kenya. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Mutation. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MIRF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of new SARS-CoV-2 mutations brought challenges and progress in the global fight against COVID-19. Mutations in spike and accessory genes affect transmission, vaccine efficacy, treatments, testing, and public health strategies. Monitoring emerging variants is crucial to halt re-emergency of the virus and spread. 44 nasopharyngeal/oropharyngeal swabs from Kenyan patients were sequenced with the Illumina platform. Galaxy’s bioinformatic tools were used for genomic analysis. SARS-CoV-2 genome classification was done using PANGOLIN and mutation annotation with the COVID-19 Annotator tool. From this study, 5 clades of SARS-CoV-2 were identified of whom 38 (86%) were BA.1.1; 2 (5%) were BA.1.1.1; 1 (2%) was BA.1; 1 (2%) was BA.1.14 and 2 (5%) were AY.46. Symptomatic patients were 16 out of 18 males and 22 out of 26 females. Out of these, symptomatic patients, BA.1.1 was found in 14 males and 18 females. In these clades we found 53 significant mutations of which 42 were non-synonymous, 10 synonymous, 7 deletions, 4 insertions and 2 extragenic. Out of the 42 non-synonymous mutations, 7 were exclusively found in symptomatic patients. Two new mutations, S:R214R, and NSP2:A555A, were also found and were dominant in symptomatic patients. These findings add to the understanding of the SARS-CoV-2 virus future evolution in the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19MutationHumansKenyaMaleFemaleGenome, ViralPhylogenyAdultMiddle AgedSpike Glycoprotein, Coronavirus

Substanzen

Spike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Laboratory Department, Moi Teaching and Referral Hospital, Eldoret, Kenya.
  • School of Medicine, Moi University, Eldoret, Kenya.
  • Center for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi, Kenya.
  • Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Laboratory Sciences, South Eastern Kenya University, Kitui, Kenya.
  • Vaccines and Therapeutics, Medical and Scientific Affairs, National Microbiology Laboratory Branch, Public Health Agency of Canada, Winnipeg, Canada.

ORCID-Profile: Elius Mbogori, Caroline Wangui Gikunyu

Förderung

  • MIRF

Zitieren

APA

Mbogori, E., Thiongo, K., Deng, H. Y., Gikunyu, C. W., Cheriro, W., Musyoki, S., Biegon, R., Matoke-Muhia, D., Patel, K., Liang, B., & Songok, E. (2025). SARS-COV-2 mutations in North Rift, Kenya. PLOS One. https://doi.org/10.1371/journal.pone.0325133

Vancouver

Mbogori E, Thiongo K, Deng HY, Gikunyu CW, Cheriro W, Musyoki S, et al. SARS-COV-2 mutations in North Rift, Kenya. PLOS One. 2025. doi:10.1371/journal.pone.0325133

BibTeX
@article{Mbogori2025,
  author = {Mbogori, Elius and Thiongo, Kelvin and Deng, Harrison Yunying and Gikunyu, Caroline Wangui and Cheriro, Winfrida and Musyoki, Stanslaus and Biegon, Richard and Matoke-Muhia, Damaris and Patel, Kirtika and Liang, Binhua and Songok, Elijah},
  title = {SARS-COV-2 mutations in North Rift, Kenya},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325133}
}
Kostenlos starten →